SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008130
Filing Date
2022-05-10
Accepted
2022-05-10 16:31:36
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tgtx-20220331x10q.htm   iXBRL 10-Q 1445299
2 EX-31.1 tgtx-20220331xex31d1.htm EX-31.1 13516
3 EX-31.2 tgtx-20220331xex31d2.htm EX-31.2 13483
4 EX-32.1 tgtx-20220331xex32d1.htm EX-32.1 6651
5 EX-32.2 tgtx-20220331xex32d2.htm EX-32.2 6589
  Complete submission text file 0001558370-22-008130.txt   5180592

Data Files

Seq Description Document Type Size
6 EX-101.SCH tgtx-20220331.xsd EX-101.SCH 42630
7 EX-101.CAL tgtx-20220331_cal.xml EX-101.CAL 54434
8 EX-101.DEF tgtx-20220331_def.xml EX-101.DEF 140262
9 EX-101.LAB tgtx-20220331_lab.xml EX-101.LAB 331485
10 EX-101.PRE tgtx-20220331_pre.xml EX-101.PRE 245201
54 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20220331x10q_htm.xml XML 706937
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 22910217
SIC: 2834 Pharmaceutical Preparations